| NCT03910101 | Long-term Efficacy of Spasticity-correcting Surgery and Botulinum Toxin Injections for Upper Limb Spasticity Treatment | Vastra Gotaland Region | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≥ 6 months
| Ended | 34 | NA | Surgery | Spasticity | - Ashworth and Modified Ashworth Scale (MAS)
- Canadian Occupational Performance Measure
- Grasp and Release Test (GRT)
| 6 months | 25 January 2019 | 10 April 2019 | 1 | |
| NCT06094205 | Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) | Massachusetts General Hospital | | - Age 18 - 80 yrs
- Level C1-T1
AIS - ≥ 12 months
| Recruiting | 2 | NA | Technology | Mental health and psychosocial factors | | 1-5 years | 16 October 2023 | 23 October 2023 | 2 | |
| NCT05730049 | Neuromodulation as an Anti-inflammatory Treatment in SCI | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
- NOT have implanted device, e.g., pacemaker.
| Recruiting | 30 | NA | Technology | General health | | 24 hours | 01 January 2024 | 15 February 2023 | 1 | |
| NCT06072001 | Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis | Apurano Pharmaceuticals GmbH | Parallel Assignment | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
- NOT have a history of addiction.
- understand German.
| Recruiting | 558 | Phase 3 | Drug | Pain | - Brief Pain Inventory (BPI)
- Depression Anxiety Stress Scale-21 (DASS-21)
- Neuropathoc Pain Symptom Inventory (NPSI)
- Pain Numeric Rating Scale (NRS)
| 52 weeks | 02 November 2023 | 10 October 2023 | 1 | |
| NCT05982171 | Transcutaneous Spinal Cord Stimulation to Promote Walking Recovery After Spinal Cord Injury | Craig Hospital | | - Age ≥ 18 yrs
- Level C4-T10
AIS B, C, D- ≤ 12 months
- must be between 5'0" and 6'4" in height
- NOT have a cauda equina injury
- NOT have cardiac or respiratory issues
| Recruiting | 30 | NA | Technology | Standing/walking/mobility | - 10 Meter Walking Test (10 MWT)
- 6-Minute Walk Test (6MWT)
- Neurogenic Bladder Symptom Score
- Neurogenic Bowel Dysfunction Score (NBD or NBDS)
- Penn Spasm Frequency Scale (PSFS)
- Walking Index for Spinal Cord Injury (WISCI) and WISCI II
| 4 weeks after the last session | 15 November 2023 | 08 August 2023 | 1 | |
| NCT05920174 | Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability | Neuracle Medical Technology(Shanghai) Co.,Ltd. | Single Group Assignment | - Age 18 - 80 yrs
- Level C1-C8
AIS A, B, C, D- ≥ 1 years
| Recruiting soon | 9 | Not Applicable | Technology | General health | | 12 months | 01 July 2023 | 27 June 2023 | 3 | |
